BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 29, Issue 28
This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (4568)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-1) series.
Item 
Count 
PDF85
WORD42
HTML2215
Figures (1-6)347
Tables (1-1)313
 Sum=3002
Featured Article
The chart showing Browse series, Download series.
Item 
Count 
Browse138
Download569
 Sum=707
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse155
Download520
 Sum=675
Jul 28, 2023 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Saengboonmee C, Sorin S, Sangkhamanon S, Chomphoo S, Indramanee S, Seubwai W, Thithuan K, Chiu CF, Okada S, Gingras MC, Wongkham S. γ-aminobutyric acid B2 receptor: A potential therapeutic target for cholangiocarcinoma in patients with diabetes mellitus. World J Gastroenterol 2023; 29(28): 4416-4432 [PMID: 37576707 DOI: 10.3748/wjg.v29.i28.4416]
URL: https://www.wjgnet.com/1007-9327/full/v29/i28/4416.htm
Number Citing Articles
1
Ronnakrit Trakoonsenathong, Ching-Feng Chiu, Charupong Saengboonmee. Glucagon-like peptide 1 receptor agonist: A potential game changer for cholangiocarcinoma. World Journal of Gastroenterology 2024; 30(34): 3862-3867 doi: 10.3748/wjg.v30.i34.3862
2
Mohammad Amin Elahi Najafi, Masato Yasui, Yuki Teramoto, Tomoyuki Tatenuma, Guiyang Jiang, Hiroshi Miyamoto. GABBR2 as a Downstream Effector of the Androgen Receptor Induces Cisplatin Resistance in Bladder Cancer. International Journal of Molecular Sciences 2023; 24(18): 13733 doi: 10.3390/ijms241813733
3
Ronnakrit Trakoonsenathong, Waritta Kunprom, Chaiwat Aphivatanasiri, Padcharee Yueangchantuek, Paslada Pimkeeree, Supannika Sorin, Kullanat Khawkhiaw, Ching-Feng Chiu, Seiji Okada, Sopit Wongkham, Charupong Saengboonmee. Liraglutide exhibits potential anti-tumor effects on the progression of intrahepatic cholangiocarcinoma, in vitro and in vivo. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-64774-2
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345